Biotricity, Inc.
BTCY
$0.6332
$0.00280.44%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.46M | 13.79M | 13.27M | 12.62M | 12.24M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.46M | 13.79M | 13.27M | 12.62M | 12.24M |
| Cost of Revenue | 3.14M | 3.23M | 3.41M | 3.36M | 3.44M |
| Gross Profit | 11.32M | 10.56M | 9.86M | 9.26M | 8.80M |
| SG&A Expenses | 10.03M | 10.86M | 12.21M | 12.82M | 14.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.51M | 16.24M | 17.90M | 18.37M | 19.87M |
| Operating Income | -1.05M | -2.45M | -4.64M | -5.75M | -7.63M |
| Income Before Tax | -5.40M | -8.42M | -10.67M | -12.25M | -14.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.40 | -8.42 | -10.67 | -12.25 | -14.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.40M | -8.42M | -10.67M | -12.25M | -14.38M |
| EBIT | -1.05M | -2.45M | -4.64M | -5.75M | -7.63M |
| EBITDA | -1.04M | -2.44M | -4.63M | -5.74M | -7.62M |
| EPS Basic | -0.23 | -0.70 | -1.08 | -1.37 | -1.74 |
| Normalized Basic EPS | -0.14 | -0.27 | -0.50 | -0.66 | -0.88 |
| EPS Diluted | -0.23 | -0.70 | -1.08 | -1.37 | -1.74 |
| Normalized Diluted EPS | -0.14 | -0.27 | -0.50 | -0.66 | -0.88 |
| Average Basic Shares Outstanding | 99.36M | 87.25M | 70.33M | 55.08M | 41.38M |
| Average Diluted Shares Outstanding | 99.36M | 87.25M | 70.33M | 55.08M | 41.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.44% | -0.36% | -0.22% | -0.20% | -0.17% |